ID   ABCA1_HUMAN             Reviewed;        2261 AA.
AC   O95477; Q5VX33; Q96S56; Q96T85; Q9NQV4; Q9UN06; Q9UN07; Q9UN08;
AC   Q9UN09;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=ATP-binding cassette sub-family A member 1;
DE   AltName: Full=ATP-binding cassette transporter 1;
DE            Short=ABC-1;
DE            Short=ATP-binding cassette 1;
DE   AltName: Full=Cholesterol efflux regulatory protein;
GN   Name=ABCA1; Synonyms=ABC1, CERP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT ARG-1587.
RX   PubMed=10884428; DOI=10.1073/pnas.97.14.7987;
RA   Santamarina-Fojo S., Peterson K.M., Knapper C.L., Qiu Y.,
RA   Freeman L.A., Cheng J.-F., Osorio J., Remaley A.T., Yang X.-P.,
RA   Haudenschild C.C., Prades C., Chimini G., Blackmon E.E.,
RA   Francois T.L., Duverger N., Rubin E.M., Rosier M., Denefle P.,
RA   Fredrickson D.S., Brewer H.B. Jr.;
RT   "Complete genomic sequence of the human ABCA1 gene: analysis of the
RT   human and mouse ATP-binding cassette A promoter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:7987-7992(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ARG-1587.
RC   TISSUE=Skin;
RA   Schwartz K., Lawn R.M., Wade D.P.;
RT   "ABCA1 gene expression and apoA-I-mediated cholesterol efflux are
RT   regulated by LXR.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-1587.
RX   PubMed=11352567; DOI=10.1006/geno.2000.6467;
RA   Qiu Y., Cavelier L., Chiu S., Yang X., Rubin E., Cheng J.-F.;
RT   "Human and mouse ABCA1 comparative sequencing and transgenesis studies
RT   revealing novel regulatory sequences.";
RL   Genomics 73:66-76(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tanaka A.R., Abe-Dohmae S., Arakawa R., Sadanami K., Kidera A.,
RA   Kioka N., Amachi T., Yokoyama S., Ueda K.;
RT   "A new topological model of functional human ABCA1-signal peptide
RT   cleavage and glycosylation of a large extracellular domain.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-2261, AND VARIANTS THR-1555;
RP   ARG-1587; PRO-1648 AND PRO-2168.
RX   PubMed=10092505; DOI=10.1006/bbrc.1999.0406;
RA   Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.-F.,
RA   Chimini G., Kaminski W.E., Schmitz G.;
RT   "Molecular cloning of the human ATP-binding cassette transporter 1
RT   (hABC1): evidence for sterol-dependent regulation in macrophages.";
RL   Biochem. Biophys. Res. Commun. 257:29-33(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 21-2261, AND VARIANTS
RP   THR-1555; ARG-1587; PRO-1648 AND PRO-2168.
RX   PubMed=10431238; DOI=10.1038/11921;
RA   Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.-C.,
RA   Deleuze J.-F., Brewer H.B. Jr., Duverger N., Denefle P., Assmann G.;
RT   "Tangier disease is caused by mutations in the gene encoding ATP-
RT   binding cassette transporter 1.";
RL   Nat. Genet. 22:352-355(1999).
RN   [8]
RP   PHOSPHORYLATION AT SER-1042 AND SER-2054.
RX   PubMed=12196520; DOI=10.1074/jbc.M204923200;
RA   See R.H., Caday-Malcolm R.A., Singaraja R.R., Zhou S., Silverston A.,
RA   Huber M.T., Moran J., James E.R., Janoo R., Savill J.M., Rigot V.,
RA   Zhang L.H., Wang M., Chimini G., Wellington C.L., Tafuri S.R.,
RA   Hayden M.R.;
RT   "Protein kinase A site-specific phosphorylation regulates ATP-binding
RT   cassette A1 (ABCA1)-mediated phospholipid efflux.";
RL   J. Biol. Chem. 277:41835-41842(2002).
RN   [9]
RP   REPRESSION BY ZNF202.
RX   PubMed=11279031; DOI=10.1074/jbc.M100218200;
RA   Porsch-Oezcueruemez M., Langmann T., Heimerl S., Borsukova H.,
RA   Kaminski W.E., Drobnik W., Honer C., Schumacher C., Schmitz G.;
RT   "The zinc finger protein 202 (ZNF202) is a transcriptional repressor
RT   of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene
RT   expression and a modulator of cellular lipid efflux.";
RL   J. Biol. Chem. 276:12427-12433(2001).
RN   [10]
RP   INDUCTION BY LPS.
RX   PubMed=12032171;
RA   Kaplan R., Gan X., Menke J.G., Wright S.D., Cai T.-Q.;
RT   "Bacterial lipopolysaccharide induces expression of ABCA1 but not
RT   ABCG1 via an LXR-independent pathway.";
RL   J. Lipid Res. 43:952-959(2002).
RN   [11]
RP   INTERACTION WITH MEGF10.
RX   PubMed=17205124; DOI=10.1371/journal.pone.0000120;
RA   Hamon Y., Trompier D., Ma Z., Venegas V., Pophillat M., Mignotte V.,
RA   Zhou Z., Chimini G.;
RT   "Cooperation between engulfment receptors: the case of ABCA1 and
RT   MEGF10.";
RL   PLoS ONE 1:E120-E120(2006).
RN   [12]
RP   REVIEW ON VARIANTS.
RX   PubMed=12763760; DOI=10.1161/01.ATV.0000078520.89539.77;
RA   Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J.P.,
RA   Hayden M.R.;
RT   "Efflux and atherosclerosis: the clinical and biochemical impact of
RT   variations in the ABCA1 gene.";
RL   Arterioscler. Thromb. Vasc. Biol. 23:1322-1332(2003).
RN   [13]
RP   POLYMORPHISM, AND INVOLVEMENT IN HDLCQ13.
RX   PubMed=18354102; DOI=10.1056/NEJMoa0706728;
RA   Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N.P.,
RA   Roos C., Hirschhorn J.N., Berglund G., Hedblad B., Groop L.,
RA   Altshuler D.M., Newton-Cheh C., Orho-Melander M.;
RT   "Polymorphisms associated with cholesterol and risk of cardiovascular
RT   events.";
RL   N. Engl. J. Med. 358:1240-1249(2008).
RN   [14]
RP   PALMITOYLATION AT CYS-3; CYS-23; CYS-1110 AND CYS-1111, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19556522; DOI=10.1161/CIRCRESAHA.108.193011;
RA   Singaraja R.R., Kang M.H., Vaid K., Sanders S.S., Vilas G.L.,
RA   Arstikaitis P., Coutinho J., Drisdel R.C., El-Husseini Ael D.,
RA   Green W.N., Berthiaume L., Hayden M.R.;
RT   "Palmitoylation of ATP-binding cassette transporter A1 is essential
RT   for its trafficking and function.";
RL   Circ. Res. 105:138-147(2009).
RN   [15]
RP   DISULFIDE BONDS, AND SUBCELLULAR LOCATION.
RX   PubMed=19258317; DOI=10.1074/jbc.M900580200;
RA   Hozoji M., Kimura Y., Kioka N., Ueda K.;
RT   "Formation of two intramolecular disulfide bonds is necessary for
RT   ApoA-I-dependent cholesterol efflux mediated by ABCA1.";
RL   J. Biol. Chem. 284:11293-11300(2009).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98 AND ASN-244.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   VARIANTS HDLD2 THR-1091 AND 1893-GLU-ASP-1894 DEL.
RX   PubMed=10533863; DOI=10.1016/S0140-6736(99)07026-9;
RA   Marcil M., Brooks-Wilson A., Clee S.M., Roomp K., Zhang L.-H., Yu L.,
RA   Collins J.A., van Dam M., Molhuizen H.O.F., Loubser O.,
RA   Ouellette B.F.F., Sensen C.W., Fichter K., Mott S., Denis M.,
RA   Boucher B., Pimstone S., Genest J. Jr., Kastelein J.J.P., Hayden M.R.;
RT   "Mutations in the ABC1 gene in familial HDL deficiency with defective
RT   cholesterol efflux.";
RL   Lancet 354:1341-1346(1999).
RN   [19]
RP   VARIANTS HDLD1 ARG-597 AND ARG-1477, AND VARIANT HDLD2 LEU-693 DEL.
RX   PubMed=10431236; DOI=10.1038/11905;
RA   Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.-H., Roomp K.,
RA   van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O.F.,
RA   Loubser O., Ouelette B.F.F., Fichter K., Ashbourne-Excoffon K.J.D.,
RA   Sensen C.W., Scherer S., Mott S., Denis M., Martindale D.,
RA   Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J.P.,
RA   Hayden M.R.;
RT   "Mutations in ABC1 in Tangier disease and familial high-density
RT   lipoprotein deficiency.";
RL   Nat. Genet. 22:336-345(1999).
RN   [20]
RP   VARIANTS HDLD1 SER-590; SER-935 AND VAL-937, AND VARIANTS ALA-399 AND
RP   MET-883.
RX   PubMed=10431237; DOI=10.1038/11914;
RA   Bodzioch M., Orso E., Klucken J., Langmann T., Boettcher A.,
RA   Diederich W., Drobnik W., Barlage S., Buechler C.,
RA   Porsch-Oezcueruemez M., Kaminski W.E., Hahmann H.W., Oette K.,
RA   Rothe G., Aslanidis C., Lackner K.J., Schmitz G.;
RT   "The gene encoding ATP-binding cassette transporter 1 is mutated in
RT   Tangier disease.";
RL   Nat. Genet. 22:347-351(1999).
RN   [21]
RP   VARIANTS HDLD1 ARG-597; ILE-929 AND ARG-1477, AND VARIANTS HDLD2
RP   LEU-693 DEL; THR-1091; 1893-GLU-ASP-1894 DEL AND LEU-2150.
RX   PubMed=11086027; DOI=10.1172/JCI10727;
RA   Clee S.M., Kastelein J.J.P., van Dam M., Marcil M., Roomp K.,
RA   Zwarts K.Y., Collins J.A., Roelants R., Tamasawa N., Stulc T.,
RA   Suda T., Ceska R., Boucher B., Rondeau C., DeSouich C.,
RA   Brooks-Wilson A., Molhuizen H.O.F., Frohlich J., Genest J. Jr.,
RA   Hayden M.R.;
RT   "Age and residual cholesterol efflux affect HDL cholesterol levels and
RT   coronary artery disease in ABCA1 heterozygotes.";
RL   J. Clin. Invest. 106:1263-1270(2000).
RN   [22]
RP   VARIANTS HDLD1 ASN-1289 AND HIS-1800.
RX   PubMed=10706591;
RA   Brousseau M.E., Schaefer E.J., Dupuis J., Eustace B.,
RA   Van Eerdewegh P., Goldkamp A.L., Thurston L.M., FitzGerald M.G.,
RA   Yasek-McKenna D., O'Neill G., Eberhart G.P., Weiffenbach B.,
RA   Ordovas J.M., Freeman M.W., Brown R.H. Jr., Gu J.Z.;
RT   "Novel mutations in the gene encoding ATP-binding cassette 1 in four
RT   tangier disease kindreds.";
RL   J. Lipid Res. 41:433-441(2000).
RN   [23]
RP   VARIANT HDLD1 ASP-1046, AND VARIANTS LYS-219; CYS-230; ILE-825;
RP   MET-883 AND ARG-1587.
RX   PubMed=10938021; DOI=10.1161/01.ATV.20.8.1983;
RA   Wang J., Burnett J.R., Near S., Young K., Zinman B., Hanley A.J.G.,
RA   Connelly P.W., Harris S.B., Hegele R.A.;
RT   "Common and rare ABCA1 variants affecting plasma HDL cholesterol.";
RL   Arterioscler. Thromb. Vasc. Biol. 20:1983-1989(2000).
RN   [24]
RP   VARIANT HDLD1 TRP-587, AND VARIANT PRO-2168.
RX   PubMed=11257260; DOI=10.1016/S0021-9150(00)00587-6;
RA   Bertolini S., Pisciotta L., Seri M., Cusano R., Cantafora A.,
RA   Calabresi L., Franceschini G., Ravazzolo R., Calandra S.;
RT   "A point mutation in ABC1 gene in a patient with severe premature
RT   coronary heart disease and mild clinical phenotype of Tangier
RT   disease.";
RL   Atherosclerosis 154:599-605(2001).
RN   [25]
RP   VARIANTS LYS-219; MET-883 AND ASP-1172.
RX   PubMed=11257261; DOI=10.1016/S0021-9150(00)00722-X;
RA   Brousseau M.E., Bodzioch M., Schaefer E.J., Goldkamp A.L., Kielar D.,
RA   Probst M., Ordovas J.M., Aslanidis C., Lackner K.J.,
RA   Bloomfield Rubins H., Collins D., Robins S.J., Wilson P.W.F.,
RA   Schmitz G.;
RT   "Common variants in the gene encoding ATP-binding cassette transporter
RT   1 in men with low HDL cholesterol levels and coronary heart disease.";
RL   Atherosclerosis 154:607-611(2001).
RN   [26]
RP   VARIANT HDLD1 LEU-1506.
RX   PubMed=11476961; DOI=10.1016/S0925-4439(01)00053-9;
RA   Lapicka-Bodzioch K., Bodzioch M., Kruell M., Kielar D., Probst M.,
RA   Kiec B., Andrikovics H., Boettcher A., Hubacek J., Aslanidis C.,
RA   Suttorp N., Schmitz G.;
RT   "Homogeneous assay based on 52 primer sets to scan for mutations of
RT   the ABCA1 gene and its application in genetic analysis of a new
RT   patient with familial high-density lipoprotein deficiency syndrome.";
RL   Biochim. Biophys. Acta 1537:42-48(2001).
RN   [27]
RP   VARIANTS HDLD1 ASN-1289 AND TRP-2081, AND VARIANT LYS-219.
RX   PubMed=11476965; DOI=10.1016/S0925-4439(01)00058-8;
RA   Huang W., Moriyama K., Koga T., Hua H., Ageta M., Kawabata S.,
RA   Mawatari K., Imamura T., Eto T., Kawamura M., Teramoto T., Sasaki J.;
RT   "Novel mutations in ABCA1 gene in Japanese patients with Tangier
RT   disease and familial high density lipoprotein deficiency with coronary
RT   heart disease.";
RL   Biochim. Biophys. Acta 1537:71-78(2001).
RN   [28]
RP   VARIANTS LYS-219; ALA-399; MET-771; PRO-774; ASN-776; ILE-825;
RP   MET-883; ASP-1172; ARG-1587 AND CYS-1731.
RX   PubMed=11238261; DOI=10.1161/01.CIR.103.9.1198;
RA   Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y.,
RA   Molhuizen H.O.F., Roomp K., Jukema J.W., van Wijland M., van Dam M.,
RA   Hudson T.J., Brooks-Wilson A., Genest J. Jr., Kastelein J.J.P.,
RA   Hayden M.R.;
RT   "Common genetic variation in ABCA1 is associated with altered
RT   lipoprotein levels and a modified risk for coronary artery disease.";
RL   Circulation 103:1198-1205(2001).
RN   [29]
RP   VARIANT HDLD2 LEU-85.
RX   PubMed=12204794; DOI=10.1016/S0021-9150(02)00106-5;
RA   Hong S.H., Rhyne J., Zeller K., Miller M.;
RT   "ABCA1(Alabama): a novel variant associated with HDL deficiency and
RT   premature coronary artery disease.";
RL   Atherosclerosis 164:245-250(2002).
RN   [30]
RP   VARIANTS HDLD2 TYR-1099 AND SER-2009.
RX   PubMed=12009425; DOI=10.1016/S0925-4439(02)00066-2;
RA   Hong S.H., Rhyne J., Zeller K., Miller M.;
RT   "Novel ABCA1 compound variant associated with HDL cholesterol
RT   deficiency.";
RL   Biochim. Biophys. Acta 1587:60-64(2002).
RN   [31]
RP   VARIANT HDLD1 THR-255, AND VARIANT ATHEROSCLEROSIS ASP-1611.
RX   PubMed=11785958; DOI=10.1006/bbrc.2001.6219;
RA   Nishida Y., Hirano K., Tsukamoto K., Nagano M., Ikegami C., Roomp K.,
RA   Ishihara M., Sakane N., Zhang Z., Tsujii K., Matsuyama A., Ohama T.,
RA   Matsuura F., Ishigami M., Sakai N., Hiraoka H., Hattori H.,
RA   Wellington C., Yoshida Y., Misugi S., Hayden M.R., Egashira T.,
RA   Yamashita S., Matsuzawa Y.;
RT   "Expression and functional analyses of novel mutations of ATP-binding
RT   cassette transporter-1 in Japanese patients with high-density
RT   lipoprotein deficiency.";
RL   Biochem. Biophys. Res. Commun. 290:713-721(2002).
RN   [32]
RP   VARIANT HDLD1 LEU-590.
RX   PubMed=12407001;
RA   Hong S.H., Riley W., Rhyne J., Friel G., Miller M.;
RT   "Lack of association between increased carotid intima-media thickening
RT   and decreased HDL-cholesterol in a family with a novel ABCA1 variant,
RT   G2265T.";
RL   Clin. Chem. 48:2066-2070(2002).
RN   [33]
RP   VARIANTS HDLD1 HIS-935 AND SER-935.
RX   PubMed=12111381; DOI=10.1007/s100380200044;
RA   Guo Z., Inazu A., Yu W., Suzumura T., Okamoto M., Nohara A.,
RA   Higashikata T., Sano R., Wakasugi K., Hayakawa T., Yoshida K.,
RA   Suehiro T., Schmitz G., Mabuchi H.;
RT   "Double deletions and missense mutations in the first nucleotide-
RT   binding fold of the ATP-binding cassette transporter A1 (ABCA1) gene
RT   in Japanese patients with Tangier disease.";
RL   J. Hum. Genet. 47:325-329(2002).
RN   [34]
RP   VARIANT HDLD1 TRP-1680.
RX   PubMed=12111371; DOI=10.1007/s100380200051;
RA   Ishii J., Nagano M., Kujiraoka T., Ishihara M., Egashira T.,
RA   Takada D., Tsuji M., Hattori H., Emi M.;
RT   "Clinical variant of Tangier disease in Japan: mutation of the ABCA1
RT   gene in hypoalphalipoproteinemia with corneal lipidosis.";
RL   J. Hum. Genet. 47:366-369(2002).
RN   [35]
RP   VARIANT HDLD1 GLN-1851.
RX   PubMed=14576201; DOI=10.1161/01.RES.0000102957.84247.8F;
RA   Hong S.H., Rhyne J., Miller M.;
RT   "Novel polypyrimidine variation (IVS46: del T -39._.-46) in ABCA1
RT   causes exon skipping and contributes to HDL cholesterol deficiency in
RT   a family with premature coronary disease.";
RL   Circ. Res. 93:1006-1012(2003).
RN   [36]
RP   VARIANTS ILE-825 AND MET-883, AND ASSOCIATION OF VARIANTS ILE-825 AND
RP   MET-883 WITH HIGHER PLASMA HDL CHOLESTEROL.
RX   PubMed=12709788; DOI=10.1007/s00439-003-0943-3;
RA   Tan J.H., Low P.S., Tan Y.S., Tong M.C., Saha N., Yang H., Heng C.K.;
RT   "ABCA1 gene polymorphisms and their associations with coronary artery
RT   disease and plasma lipids in males from three ethnic populations in
RT   Singapore.";
RL   Hum. Genet. 113:106-117(2003).
RN   [37]
RP   VARIANTS LYS-219; MET-771; ILE-825; MET-883; ASP-1172; PHE-1181 AND
RP   ARG-1587.
RX   PubMed=12966036; DOI=10.1093/hmg/ddg314;
RA   Morabia A., Cayanis E., Costanza M.C., Ross B.M., Flaherty M.S.,
RA   Alvin G.B., Das K., Gilliam T.C.;
RT   "Association of extreme blood lipid profile phenotypic variation with
RT   11 reverse cholesterol transport genes and 10 non-genetic
RT   cardiovascular disease risk factors.";
RL   Hum. Mol. Genet. 12:2733-2743(2003).
RN   [38]
RP   VARIANT LYS-219.
RX   PubMed=12624133; DOI=10.1136/jmg.40.3.163;
RA   Cenarro A., Artieda M., Castillo S., Mozas P., Reyes G., Tejedor D.,
RA   Alonso R., Mata P., Pocovi M., Civeira F.;
RT   "A common variant in the ABCA1 gene is associated with a lower risk
RT   for premature coronary heart disease in familial
RT   hypercholesterolaemia.";
RL   J. Med. Genet. 40:163-168(2003).
RN   [39]
RP   VARIANTS HDLD1 LEU-590; ARG-840 AND CYS-1068, AND VARIANTS MET-771;
RP   SER-2163 AND ILE-2244.
RX   PubMed=15262183; DOI=10.1016/j.atherosclerosis.2004.02.019;
RA   Probst M.C., Thumann H., Aslanidis C., Langmann T., Buechler C.,
RA   Patsch W., Baralle F.E., Dallinga-Thie G.M., Geisel J., Keller C.,
RA   Menys V.C., Schmitz G.;
RT   "Screening for functional sequence variations and mutations in
RT   ABCA1.";
RL   Atherosclerosis 175:269-279(2004).
RN   [40]
RP   VARIANTS HDLD1 LYS-284; CYS-482; HIS-1800; SER-1901 AND HIS-2196.
RX   PubMed=15019541; DOI=10.1016/j.atherosclerosis.2003.11.009;
RA   Pisciotta L., Hamilton-Craig I., Tarugi P., Bellocchio A., Fasano T.,
RA   Alessandrini P., Bon G.B., Siepi D., Mannarino E., Cattin L.,
RA   Averna M., Cefalu A.B., Cantafora A., Calandra S., Bertolini S.;
RT   "Familial HDL deficiency due to ABCA1 gene mutations with or without
RT   other genetic lipoprotein disorders.";
RL   Atherosclerosis 172:309-320(2004).
RN   [41]
RP   VARIANTS HDLD1 PHE-1379 AND ASP-1704, AND CHARACTERIZATION OF VARIANTS
RP   HDLD1 PHE-1379 AND ASP-1704.
RX   PubMed=15158913; DOI=10.1016/j.bbadis.2004.01.007;
RA   Albrecht C., Baynes K., Sardini A., Schepelmann S., Eden E.R.,
RA   Davies S.W., Higgins C.F., Feher M.D., Owen J.S., Soutar A.K.;
RT   "Two novel missense mutations in ABCA1 result in altered trafficking
RT   and cause severe autosomal recessive HDL deficiency.";
RL   Biochim. Biophys. Acta 1689:47-57(2004).
RN   [42]
RP   VARIANT HDLD1 HIS-1800, AND VARIANTS LYS-219; CYS-364; MET-771;
RP   PRO-774; ASN-776; ILE-825; MET-883; SER-1065; ASP-1172; VAL-1216 AND
RP   ARG-1587.
RX   PubMed=15520867; DOI=10.1172/JCI200420361;
RA   Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Tybjaerg-Hansen A.;
RT   "Genetic variation in ABC transporter A1 contributes to HDL
RT   cholesterol in the general population.";
RL   J. Clin. Invest. 114:1343-1353(2004).
RN   [43]
RP   VARIANT HDLD1 HIS-1800, AND VARIANTS ALA-248; GLN-401; TRP-496;
RP   SER-590; GLN-638; SER-774; GLY-815; PHE-1181; THR-1341; GLY-1376;
RP   GLN-1615; THR-1670; GLN-1680 AND GLU-2243.
RX   PubMed=15297675; DOI=10.1126/science.1099870;
RA   Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R.,
RA   Hobbs H.H.;
RT   "Multiple rare alleles contribute to low plasma levels of HDL
RT   cholesterol.";
RL   Science 305:869-872(2004).
RN   [44]
RP   VARIANT SCOTT SYNDROME GLN-1925, AND CHARACTERIZATION OF VARIANT SCOTT
RP   SYNDROME GLN-1925.
RX   PubMed=15790791; DOI=10.1182/blood-2004-05-2056;
RA   Albrecht C., McVey J.H., Elliott J.I., Sardini A., Kasza I.,
RA   Mumford A.D., Naoumova R.P., Tuddenham E.G., Szabo K., Higgins C.F.;
RT   "A novel missense mutation in ABCA1 results in altered protein
RT   trafficking and reduced phosphatidylserine translocation in a patient
RT   with Scott syndrome.";
RL   Blood 106:542-549(2005).
RN   [45]
RP   VARIANT ASN-776, AND ASSOCIATION OF VARIANT ASN-776 WITH INCREASED
RP   RISK OF ISCHEMIC HEART DISEASE.
RX   PubMed=16226177; DOI=10.1016/j.jacc.2005.06.066;
RA   Frikke-Schmidt R., Nordestgaard B.G., Schnohr P., Steffensen R.,
RA   Tybjaerg-Hansen A.;
RT   "Mutation in ABCA1 predicted risk of ischemic heart disease in the
RT   Copenhagen City Heart Study Population.";
RL   J. Am. Coll. Cardiol. 46:1516-1520(2005).
RN   [46]
RP   VARIANT HDLD2 TRP-1897.
RX   PubMed=15722566; DOI=10.1194/jlr.D400038-JLR200;
RA   Fasano T., Bocchi L., Pisciotta L., Bertolini S., Calandra S.;
RT   "Denaturing high-performance liquid chromatography in the detection of
RT   ABCA1 gene mutations in familial HDL deficiency.";
RL   J. Lipid Res. 46:817-822(2005).
RN   [47]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-210; TYR-917; THR-1407 AND
RP   THR-2109.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [48]
RP   VARIANT CYS-230.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: cAMP-dependent and sulfonylurea-sensitive anion
CC       transporter. Key gatekeeper influencing intracellular cholesterol
CC       transport.
CC   -!- SUBUNIT: Interacts with MEGF10. {ECO:0000269|PubMed:17205124}.
CC   -!- INTERACTION:
CC       Q86UK0:ABCA12; NbExp=4; IntAct=EBI-784112, EBI-9541582;
CC       P02647:APOA1; NbExp=4; IntAct=EBI-784112, EBI-701692;
CC       P60953:CDC42; NbExp=2; IntAct=EBI-784112, EBI-81752;
CC       P55055:NR1H2; NbExp=2; IntAct=EBI-784112, EBI-745354;
CC       Q13424:SNTA1; NbExp=2; IntAct=EBI-784112, EBI-717191;
CC       Q13884:SNTB1; NbExp=3; IntAct=EBI-784112, EBI-295843;
CC       Q86Y82:STX12; NbExp=9; IntAct=EBI-784112, EBI-2691717;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:19258317,
CC       ECO:0000269|PubMed:19556522}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19258317, ECO:0000269|PubMed:19556522}.
CC   -!- TISSUE SPECIFICITY: Widely expressed, but most abundant in
CC       macrophages.
CC   -!- INDUCTION: By bacterial lipopolysaccharides (LPS). LPS regulates
CC       expression through a liver X receptor (LXR) -independent
CC       mechanism. Repressed by ZNF202. {ECO:0000269|PubMed:11279031,
CC       ECO:0000269|PubMed:12032171}.
CC   -!- DOMAIN: Multifunctional polypeptide with two homologous halves,
CC       each containing a hydrophobic membrane-anchoring domain and an ATP
CC       binding cassette (ABC) domain.
CC   -!- PTM: Phosphorylation on Ser-2054 regulates phospholipid efflux.
CC       {ECO:0000269|PubMed:12196520}.
CC   -!- PTM: Palmitoylation by DHHC8 is essential for membrane
CC       localization. {ECO:0000269|PubMed:19556522}.
CC   -!- POLYMORPHISM: Genetic variations in ABCA1 define the high density
CC       lipoprotein cholesterol level quantitative trait locus 13
CC       (HDLCQ13) [MIM:600046]. {ECO:0000269|PubMed:18354102}.
CC   -!- DISEASE: High density lipoprotein deficiency 1 (HDLD1)
CC       [MIM:205400]: Recessive disorder characterized by absence of high
CC       density lipoprotein (HDL) cholesterol from plasma, accumulation of
CC       cholesteryl esters, premature coronary artery disease (CAD),
CC       hepatosplenomegaly, recurrent peripheral neuropathy and
CC       progressive muscle wasting and weakness.
CC       {ECO:0000269|PubMed:10431236, ECO:0000269|PubMed:10431237,
CC       ECO:0000269|PubMed:10706591, ECO:0000269|PubMed:10938021,
CC       ECO:0000269|PubMed:11086027, ECO:0000269|PubMed:11257260,
CC       ECO:0000269|PubMed:11476961, ECO:0000269|PubMed:11476965,
CC       ECO:0000269|PubMed:11785958, ECO:0000269|PubMed:12111371,
CC       ECO:0000269|PubMed:12111381, ECO:0000269|PubMed:12407001,
CC       ECO:0000269|PubMed:14576201, ECO:0000269|PubMed:15019541,
CC       ECO:0000269|PubMed:15158913, ECO:0000269|PubMed:15262183,
CC       ECO:0000269|PubMed:15297675, ECO:0000269|PubMed:15520867}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: High density lipoprotein deficiency 2 (HDLD2)
CC       [MIM:604091]: Inherited as autosomal dominant trait. It is
CC       characterized by moderately low HDL cholesterol, predilection
CC       toward premature coronary artery disease (CAD) and a reduction in
CC       cellular cholesterol efflux. {ECO:0000269|PubMed:10431236,
CC       ECO:0000269|PubMed:10533863, ECO:0000269|PubMed:11086027,
CC       ECO:0000269|PubMed:12009425, ECO:0000269|PubMed:12204794,
CC       ECO:0000269|PubMed:15722566}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCA
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD49849.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA10005.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ABCA1";
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=O95477";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF275948; AAF86276.1; -; Genomic_DNA.
DR   EMBL; AL353685; CAH72444.1; -; Genomic_DNA.
DR   EMBL; AL359846; CAH72444.1; JOINED; Genomic_DNA.
DR   EMBL; AL359846; CAH73579.1; -; Genomic_DNA.
DR   EMBL; AL353685; CAH73579.1; JOINED; Genomic_DNA.
DR   EMBL; AF285167; AAF98175.1; -; mRNA.
DR   EMBL; AF287262; AAK43526.1; -; Genomic_DNA.
DR   EMBL; AB055982; BAB63210.1; -; mRNA.
DR   EMBL; AJ012376; CAA10005.1; ALT_INIT; mRNA.
DR   EMBL; AF165281; AAD49849.1; ALT_INIT; mRNA.
DR   EMBL; AF165286; AAD49851.1; -; Genomic_DNA.
DR   EMBL; AF165282; AAD49851.1; JOINED; Genomic_DNA.
DR   EMBL; AF165283; AAD49851.1; JOINED; Genomic_DNA.
DR   EMBL; AF165284; AAD49851.1; JOINED; Genomic_DNA.
DR   EMBL; AF165285; AAD49851.1; JOINED; Genomic_DNA.
DR   EMBL; AF165306; AAD49852.1; -; Genomic_DNA.
DR   EMBL; AF165287; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165288; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165289; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165290; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165291; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165292; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165293; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165294; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165295; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165296; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165297; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165298; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165299; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165300; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165301; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165302; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165303; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165304; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165305; AAD49852.1; JOINED; Genomic_DNA.
DR   EMBL; AF165309; AAD49854.1; -; Genomic_DNA.
DR   EMBL; AF165307; AAD49854.1; JOINED; Genomic_DNA.
DR   EMBL; AF165308; AAD49854.1; JOINED; Genomic_DNA.
DR   EMBL; AF165310; AAD49853.1; -; Genomic_DNA.
DR   CCDS; CCDS6762.1; -.
DR   RefSeq; NP_005493.2; NM_005502.3.
DR   UniGene; Hs.659274; -.
DR   ProteinModelPortal; O95477; -.
DR   SMR; O95477; -.
DR   BioGrid; 106537; 23.
DR   DIP; DIP-29211N; -.
DR   IntAct; O95477; 23.
DR   MINT; MINT-239561; -.
DR   STRING; 9606.ENSP00000363868; -.
DR   ChEMBL; CHEMBL2362986; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01599; Probucol.
DR   SwissLipids; SLP:000000345; -.
DR   TCDB; 3.A.1.211.14; the atp-binding cassette (abc) superfamily.
DR   iPTMnet; O95477; -.
DR   PhosphoSitePlus; O95477; -.
DR   SwissPalm; O95477; -.
DR   BioMuta; ABCA1; -.
DR   EPD; O95477; -.
DR   MaxQB; O95477; -.
DR   PaxDb; O95477; -.
DR   PeptideAtlas; O95477; -.
DR   PRIDE; O95477; -.
DR   Ensembl; ENST00000374736; ENSP00000363868; ENSG00000165029.
DR   GeneID; 19; -.
DR   KEGG; hsa:19; -.
DR   UCSC; uc004bcl.4; human.
DR   CTD; 19; -.
DR   DisGeNET; 19; -.
DR   GeneCards; ABCA1; -.
DR   HGNC; HGNC:29; ABCA1.
DR   HPA; CAB069889; -.
DR   HPA; HPA057283; -.
DR   MalaCards; ABCA1; -.
DR   MIM; 205400; phenotype.
DR   MIM; 600046; gene+phenotype.
DR   MIM; 604091; phenotype.
DR   neXtProt; NX_O95477; -.
DR   OpenTargets; ENSG00000165029; -.
DR   Orphanet; 425; Apolipoprotein A-I deficiency.
DR   Orphanet; 31150; Tangier disease.
DR   PharmGKB; PA24373; -.
DR   eggNOG; KOG0059; Eukaryota.
DR   eggNOG; COG1131; LUCA.
DR   GeneTree; ENSGT00760000118965; -.
DR   HOVERGEN; HBG050436; -.
DR   InParanoid; O95477; -.
DR   KO; K05641; -.
DR   OMA; KRMSEIC; -.
DR   OrthoDB; EOG091G007E; -.
DR   PhylomeDB; O95477; -.
DR   TreeFam; TF105191; -.
DR   Reactome; R-HSA-194223; HDL-mediated lipid transport.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   SignaLink; O95477; -.
DR   SIGNOR; O95477; -.
DR   ChiTaRS; ABCA1; human.
DR   GeneWiki; ABCA1; -.
DR   GenomeRNAi; 19; -.
DR   PRO; PR:O95477; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165029; -.
DR   ExpressionAtlas; O95477; baseline and differential.
DR   Genevisible; O95477; HS.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0008509; F:anion transmembrane transporter activity; ISS:BHF-UCL.
DR   GO; GO:0034186; F:apolipoprotein A-I binding; IPI:BHF-UCL.
DR   GO; GO:0034188; F:apolipoprotein A-I receptor activity; IDA:BHF-UCL.
DR   GO; GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:GO_Central.
DR   GO; GO:0051117; F:ATPase binding; IPI:BHF-UCL.
DR   GO; GO:0015485; F:cholesterol binding; IC:BHF-UCL.
DR   GO; GO:0017127; F:cholesterol transporter activity; IDA:BHF-UCL.
DR   GO; GO:0090554; F:phosphatidylcholine-translocating ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0090556; F:phosphatidylserine-translocating ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0005543; F:phospholipid binding; IC:BHF-UCL.
DR   GO; GO:0005548; F:phospholipid transporter activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0031267; F:small GTPase binding; IPI:BHF-UCL.
DR   GO; GO:0019905; F:syntaxin binding; IPI:BHF-UCL.
DR   GO; GO:0071397; P:cellular response to cholesterol; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0033344; P:cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016197; P:endosomal transport; IDA:BHF-UCL.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; IMP:BHF-UCL.
DR   GO; GO:0050702; P:interleukin-1 beta secretion; IMP:BHF-UCL.
DR   GO; GO:0032367; P:intracellular cholesterol transport; IMP:BHF-UCL.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0007040; P:lysosome organization; IDA:BHF-UCL.
DR   GO; GO:0010887; P:negative regulation of cholesterol storage; TAS:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; TAS:BHF-UCL.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:0033700; P:phospholipid efflux; IDA:BHF-UCL.
DR   GO; GO:0055091; P:phospholipid homeostasis; IMP:BHF-UCL.
DR   GO; GO:0045332; P:phospholipid translocation; IDA:BHF-UCL.
DR   GO; GO:0060155; P:platelet dense granule organization; IMP:BHF-UCL.
DR   GO; GO:0030819; P:positive regulation of cAMP biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; IMP:BHF-UCL.
DR   GO; GO:0006497; P:protein lipidation; IEA:Ensembl.
DR   GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; IMP:BHF-UCL.
DR   GO; GO:0090107; P:regulation of high-density lipoprotein particle assembly; TAS:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0034616; P:response to laminar fluid shear stress; IEP:BHF-UCL.
DR   GO; GO:0055098; P:response to low-density lipoprotein particle; IEP:BHF-UCL.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR026082; ABC_A.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR19229; PTHR19229; 1.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   Atherosclerosis; ATP-binding; Cholesterol metabolism;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Lipid metabolism; Lipoprotein; Membrane; Nucleotide-binding;
KW   Palmitate; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Steroid metabolism; Sterol metabolism; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   2261       ATP-binding cassette sub-family A member
FT                                1.
FT                                /FTId=PRO_0000093288.
FT   TRANSMEM     22     42       Helical. {ECO:0000255}.
FT   TOPO_DOM     43    639       Extracellular.
FT   TRANSMEM    640    660       Helical. {ECO:0000255}.
FT   TRANSMEM    683    703       Helical. {ECO:0000255}.
FT   TRANSMEM    716    736       Helical. {ECO:0000255}.
FT   TRANSMEM    745    765       Helical. {ECO:0000255}.
FT   TRANSMEM    777    797       Helical. {ECO:0000255}.
FT   TRANSMEM    827    847       Helical. {ECO:0000255}.
FT   TRANSMEM   1041   1057       Helical. {ECO:0000255}.
FT   TRANSMEM   1351   1371       Helical. {ECO:0000255}.
FT   TOPO_DOM   1372   1656       Extracellular.
FT   TRANSMEM   1657   1677       Helical. {ECO:0000255}.
FT   TRANSMEM   1703   1723       Helical. {ECO:0000255}.
FT   TRANSMEM   1735   1755       Helical. {ECO:0000255}.
FT   TRANSMEM   1768   1788       Helical. {ECO:0000255}.
FT   TRANSMEM   1802   1822       Helical. {ECO:0000255}.
FT   TRANSMEM   1852   1872       Helical. {ECO:0000255}.
FT   DOMAIN      899   1131       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN     1912   2144       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     933    940       ATP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND    1946   1953       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   MOD_RES    1042   1042       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:12196520}.
FT   MOD_RES    1296   1296       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P41233}.
FT   MOD_RES    2054   2054       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:12196520}.
FT   LIPID         3      3       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:19556522}.
FT   LIPID        23     23       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:19556522}.
FT   LIPID      1110   1110       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:19556522}.
FT   LIPID      1111   1111       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:19556522}.
FT   CARBOHYD     14     14       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    196    196       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    244    244       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    337    337       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    349    349       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    489    489       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    521    521       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    820    820       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1144   1144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1294   1294       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1453   1453       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1504   1504       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1637   1637       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2044   2044       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2238   2238       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     75    309       {ECO:0000269|PubMed:19258317}.
FT   DISULFID   1463   1477       {ECO:0000269|PubMed:19258317}.
FT   VARIANT      85     85       P -> L (in HDLD2; Alabama;
FT                                dbSNP:rs145183203).
FT                                {ECO:0000269|PubMed:12204794}.
FT                                /FTId=VAR_017529.
FT   VARIANT     210    210       E -> D (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035724.
FT   VARIANT     219    219       R -> K (common polymorphism; associated
FT                                with a decreased severity of CAD;
FT                                dbSNP:rs2230806).
FT                                {ECO:0000269|PubMed:10938021,
FT                                ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:11257261,
FT                                ECO:0000269|PubMed:11476965,
FT                                ECO:0000269|PubMed:12624133,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012618.
FT   VARIANT     230    230       R -> C (in dbSNP:rs9282541).
FT                                {ECO:0000269|PubMed:10938021,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_012619.
FT   VARIANT     248    248       P -> A (in dbSNP:rs142625938).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062481.
FT   VARIANT     255    255       A -> T (in HDLD1; deficient cellular
FT                                cholesterol efflux; dbSNP:rs758100110).
FT                                {ECO:0000269|PubMed:11785958}.
FT                                /FTId=VAR_012620.
FT   VARIANT     284    284       E -> K (in HDLD1).
FT                                {ECO:0000269|PubMed:15019541}.
FT                                /FTId=VAR_062482.
FT   VARIANT     364    364       S -> C (in dbSNP:rs775035559).
FT                                {ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_062483.
FT   VARIANT     399    399       V -> A (in dbSNP:rs9282543).
FT                                {ECO:0000269|PubMed:10431237,
FT                                ECO:0000269|PubMed:11238261}.
FT                                /FTId=VAR_009145.
FT   VARIANT     401    401       K -> Q (in dbSNP:rs138487227).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062484.
FT   VARIANT     482    482       Y -> C (in HDLD1).
FT                                {ECO:0000269|PubMed:15019541}.
FT                                /FTId=VAR_062485.
FT   VARIANT     496    496       R -> W (associated with increased plasma
FT                                HDL cholesterol; dbSNP:rs147675550).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062486.
FT   VARIANT     587    587       R -> W (in HDLD1; dbSNP:rs2853574).
FT                                {ECO:0000269|PubMed:11257260}.
FT                                /FTId=VAR_009146.
FT   VARIANT     590    590       W -> L (in HDLD1; dbSNP:rs137854496).
FT                                {ECO:0000269|PubMed:12407001,
FT                                ECO:0000269|PubMed:15262183}.
FT                                /FTId=VAR_062487.
FT   VARIANT     590    590       W -> S (in HDLD1; dbSNP:rs137854496).
FT                                {ECO:0000269|PubMed:10431237,
FT                                ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_009147.
FT   VARIANT     597    597       Q -> R (in HDLD1; dbSNP:rs2853578).
FT                                {ECO:0000269|PubMed:10431236,
FT                                ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_009148.
FT   VARIANT     638    638       R -> Q (associated with reduced plasma
FT                                HDL cholesterol; dbSNP:rs374190304).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062488.
FT   VARIANT     693    693       Missing (in HDLD2).
FT                                {ECO:0000269|PubMed:10431236,
FT                                ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_009149.
FT   VARIANT     771    771       V -> M (associated with HDL cholesterol;
FT                                dbSNP:rs2066718).
FT                                {ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15262183,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012621.
FT   VARIANT     774    774       T -> P (in dbSNP:rs35819696).
FT                                {ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012622.
FT   VARIANT     774    774       T -> S. {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062489.
FT   VARIANT     776    776       K -> N (may be associated with increased
FT                                risk of ischemic heart disease;
FT                                dbSNP:rs138880920).
FT                                {ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:15520867,
FT                                ECO:0000269|PubMed:16226177}.
FT                                /FTId=VAR_012623.
FT   VARIANT     815    815       E -> G (associated with reduced plasma
FT                                HDL cholesterol; dbSNP:rs145582736).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062490.
FT   VARIANT     825    825       V -> I (associated with higher plasma
FT                                cholesterol; dbSNP:rs2066715).
FT                                {ECO:0000269|PubMed:10938021,
FT                                ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:12709788,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012624.
FT   VARIANT     840    840       W -> R (in HDLD1).
FT                                {ECO:0000269|PubMed:15262183}.
FT                                /FTId=VAR_062491.
FT   VARIANT     883    883       I -> M (associated with higher plasma
FT                                cholesterol; dbSNP:rs2066714).
FT                                {ECO:0000269|PubMed:10431237,
FT                                ECO:0000269|PubMed:10938021,
FT                                ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:11257261,
FT                                ECO:0000269|PubMed:12709788,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012625.
FT   VARIANT     917    917       D -> Y (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035725.
FT   VARIANT     929    929       T -> I (in HDLD1).
FT                                {ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_012626.
FT   VARIANT     935    935       N -> H (in HDLD1; dbSNP:rs28937314).
FT                                {ECO:0000269|PubMed:12111381}.
FT                                /FTId=VAR_037968.
FT   VARIANT     935    935       N -> S (in HDLD1; dbSNP:rs28937313).
FT                                {ECO:0000269|PubMed:10431237,
FT                                ECO:0000269|PubMed:12111381}.
FT                                /FTId=VAR_009150.
FT   VARIANT     937    937       A -> V (in HDLD1; dbSNP:rs137854495).
FT                                {ECO:0000269|PubMed:10431237}.
FT                                /FTId=VAR_009151.
FT   VARIANT    1046   1046       A -> D (in HDLD1; dbSNP:rs141021096).
FT                                {ECO:0000269|PubMed:10938021}.
FT                                /FTId=VAR_012627.
FT   VARIANT    1054   1054       V -> I (in dbSNP:rs13306072).
FT                                /FTId=VAR_037969.
FT   VARIANT    1065   1065       P -> S. {ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_062492.
FT   VARIANT    1068   1068       R -> C (in HDLD1; dbSNP:rs745593394).
FT                                {ECO:0000269|PubMed:15262183}.
FT                                /FTId=VAR_062493.
FT   VARIANT    1091   1091       M -> T (in HDLD2).
FT                                {ECO:0000269|PubMed:10533863,
FT                                ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_012628.
FT   VARIANT    1099   1099       D -> Y (in HDLD2; dbSNP:rs28933692).
FT                                {ECO:0000269|PubMed:12009425}.
FT                                /FTId=VAR_017530.
FT   VARIANT    1172   1172       E -> D (associated with premature
FT                                coronary heart disease;
FT                                dbSNP:rs33918808).
FT                                {ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:11257261,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_012629.
FT   VARIANT    1181   1181       S -> F (associated with reduced plasma
FT                                HDL cholesterol; dbSNP:rs76881554).
FT                                {ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_017016.
FT   VARIANT    1216   1216       G -> V (in dbSNP:rs562403512).
FT                                {ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_062494.
FT   VARIANT    1289   1289       D -> N (in HDLD1; dbSNP:rs137854500).
FT                                {ECO:0000269|PubMed:10706591,
FT                                ECO:0000269|PubMed:11476965}.
FT                                /FTId=VAR_009152.
FT   VARIANT    1341   1341       R -> T (associated with reduced plasma
FT                                HDL cholesterol; dbSNP:rs147743782).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062495.
FT   VARIANT    1376   1376       S -> G (in dbSNP:rs145689805).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062496.
FT   VARIANT    1379   1379       L -> F (in HDLD1; the mutant protein is
FT                                retained in the endoplasmic reticulum
FT                                while the wild-type protein is located at
FT                                the plasma membrane).
FT                                {ECO:0000269|PubMed:15158913}.
FT                                /FTId=VAR_062497.
FT   VARIANT    1407   1407       A -> T (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs189206655).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035726.
FT   VARIANT    1477   1477       C -> R (in HDLD1; dbSNP:rs137854494).
FT                                {ECO:0000269|PubMed:10431236,
FT                                ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_009153.
FT   VARIANT    1506   1506       S -> L (in HDLD1; dbSNP:rs137854497).
FT                                {ECO:0000269|PubMed:11476961}.
FT                                /FTId=VAR_012630.
FT   VARIANT    1517   1517       I -> R (in HDLD1).
FT                                /FTId=VAR_009154.
FT   VARIANT    1555   1555       I -> T (in dbSNP:rs1997618).
FT                                {ECO:0000269|PubMed:10092505,
FT                                ECO:0000269|PubMed:10431238}.
FT                                /FTId=VAR_012638.
FT   VARIANT    1587   1587       K -> R (associated with HDL cholesterol;
FT                                dbSNP:rs2230808).
FT                                {ECO:0000269|PubMed:10092505,
FT                                ECO:0000269|PubMed:10431238,
FT                                ECO:0000269|PubMed:10884428,
FT                                ECO:0000269|PubMed:10938021,
FT                                ECO:0000269|PubMed:11238261,
FT                                ECO:0000269|PubMed:11352567,
FT                                ECO:0000269|PubMed:12966036,
FT                                ECO:0000269|PubMed:15520867,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_012631.
FT   VARIANT    1611   1611       N -> D (probable disease-associated
FT                                mutation; associated with
FT                                atherosclerosis; deficient cellular
FT                                cholesterol efflux).
FT                                {ECO:0000269|PubMed:11785958}.
FT                                /FTId=VAR_012632.
FT   VARIANT    1615   1615       R -> Q (associated with reduced plasma
FT                                HDL cholesterol).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062498.
FT   VARIANT    1648   1648       L -> P (in dbSNP:rs1883024).
FT                                {ECO:0000269|PubMed:10092505,
FT                                ECO:0000269|PubMed:10431238}.
FT                                /FTId=VAR_012639.
FT   VARIANT    1670   1670       A -> T (associated with reduced plasma
FT                                HDL cholesterol).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062499.
FT   VARIANT    1680   1680       R -> Q (associated with increased plasma
FT                                HDL cholesterol; dbSNP:rs150125857).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062500.
FT   VARIANT    1680   1680       R -> W (in HDLD1; dbSNP:rs137854498).
FT                                {ECO:0000269|PubMed:12111371}.
FT                                /FTId=VAR_037970.
FT   VARIANT    1704   1704       V -> D (in HDLD1; the mutant protein is
FT                                retained in the endoplasmic reticulum
FT                                while the wild-type protein is located at
FT                                the plasma membrane).
FT                                {ECO:0000269|PubMed:15158913}.
FT                                /FTId=VAR_062501.
FT   VARIANT    1731   1731       S -> C (in dbSNP:rs760507032).
FT                                {ECO:0000269|PubMed:11238261}.
FT                                /FTId=VAR_012633.
FT   VARIANT    1800   1800       N -> H (in HDLD1; dbSNP:rs146292819).
FT                                {ECO:0000269|PubMed:10706591,
FT                                ECO:0000269|PubMed:15019541,
FT                                ECO:0000269|PubMed:15297675,
FT                                ECO:0000269|PubMed:15520867}.
FT                                /FTId=VAR_009155.
FT   VARIANT    1851   1851       R -> Q (in HDLD1).
FT                                {ECO:0000269|PubMed:14576201}.
FT                                /FTId=VAR_062502.
FT   VARIANT    1893   1894       Missing (in HDLD2).
FT                                {ECO:0000269|PubMed:10533863,
FT                                ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_012634.
FT   VARIANT    1897   1897       R -> W (in HDLD2; uncertain pathological
FT                                significance; dbSNP:rs760768125).
FT                                {ECO:0000269|PubMed:15722566}.
FT                                /FTId=VAR_062503.
FT   VARIANT    1901   1901       R -> S (in HDLD1).
FT                                {ECO:0000269|PubMed:15019541}.
FT                                /FTId=VAR_062504.
FT   VARIANT    1925   1925       R -> Q (in Scott syndrome; shows impaired
FT                                trafficking of the mutant protein to the
FT                                plasma membrane; dbSNP:rs142688906).
FT                                {ECO:0000269|PubMed:15790791}.
FT                                /FTId=VAR_062505.
FT   VARIANT    2009   2009       F -> S (in HDLD2; dbSNP:rs137854499).
FT                                {ECO:0000269|PubMed:12009425}.
FT                                /FTId=VAR_037971.
FT   VARIANT    2081   2081       R -> W (in HDLD1; dbSNP:rs137854501).
FT                                {ECO:0000269|PubMed:11476965}.
FT                                /FTId=VAR_012635.
FT   VARIANT    2109   2109       A -> T (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035727.
FT   VARIANT    2150   2150       P -> L (in HDLD2; dbSNP:rs369098049).
FT                                {ECO:0000269|PubMed:11086027}.
FT                                /FTId=VAR_012636.
FT   VARIANT    2163   2163       F -> S (could be associated with reduced
FT                                plasma HDL cholesterol).
FT                                {ECO:0000269|PubMed:15262183}.
FT                                /FTId=VAR_062506.
FT   VARIANT    2168   2168       L -> P (in dbSNP:rs2853577).
FT                                {ECO:0000269|PubMed:10092505,
FT                                ECO:0000269|PubMed:10431238,
FT                                ECO:0000269|PubMed:11257260}.
FT                                /FTId=VAR_012637.
FT   VARIANT    2196   2196       Q -> H (in HDLD1; dbSNP:rs564764153).
FT                                {ECO:0000269|PubMed:15019541}.
FT                                /FTId=VAR_062507.
FT   VARIANT    2243   2243       D -> E (in dbSNP:rs34879708).
FT                                {ECO:0000269|PubMed:15297675}.
FT                                /FTId=VAR_062508.
FT   VARIANT    2244   2244       V -> I (could be associated with reduced
FT                                plasma HDL cholesterol;
FT                                dbSNP:rs144588452).
FT                                {ECO:0000269|PubMed:15262183}.
FT                                /FTId=VAR_062509.
FT   CONFLICT    793    793       Y -> C (in Ref. 3; AAK43526).
FT                                {ECO:0000305}.
FT   CONFLICT    831    831       D -> N (in Ref. 3; AAK43526).
FT                                {ECO:0000305}.
FT   CONFLICT   1005   1005       E -> K (in Ref. 3; AAK43526).
FT                                {ECO:0000305}.
FT   CONFLICT   1745   1746       Missing (in Ref. 7; AAD49852).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2261 AA;  254302 MW;  21A2CF8F3F518D6D CRC64;
     MACWPQLRLL LWKNLTFRRR QTCQLLLEVA WPLFIFLILI SVRLSYPPYE QHECHFPNKA
     MPSAGTLPWV QGIICNANNP CFRYPTPGEA PGVVGNFNKS IVARLFSDAR RLLLYSQKDT
     SMKDMRKVLR TLQQIKKSSS NLKLQDFLVD NETFSGFLYH NLSLPKSTVD KMLRADVILH
     KVFLQGYQLH LTSLCNGSKS EEMIQLGDQE VSELCGLPRE KLAAAERVLR SNMDILKPIL
     RTLNSTSPFP SKELAEATKT LLHSLGTLAQ ELFSMRSWSD MRQEVMFLTN VNSSSSSTQI
     YQAVSRIVCG HPEGGGLKIK SLNWYEDNNY KALFGGNGTE EDAETFYDNS TTPYCNDLMK
     NLESSPLSRI IWKALKPLLV GKILYTPDTP ATRQVMAEVN KTFQELAVFH DLEGMWEELS
     PKIWTFMENS QEMDLVRMLL DSRDNDHFWE QQLDGLDWTA QDIVAFLAKH PEDVQSSNGS
     VYTWREAFNE TNQAIRTISR FMECVNLNKL EPIATEVWLI NKSMELLDER KFWAGIVFTG
     ITPGSIELPH HVKYKIRMDI DNVERTNKIK DGYWDPGPRA DPFEDMRYVW GGFAYLQDVV
     EQAIIRVLTG TEKKTGVYMQ QMPYPCYVDD IFLRVMSRSM PLFMTLAWIY SVAVIIKGIV
     YEKEARLKET MRIMGLDNSI LWFSWFISSL IPLLVSAGLL VVILKLGNLL PYSDPSVVFV
     FLSVFAVVTI LQCFLISTLF SRANLAAACG GIIYFTLYLP YVLCVAWQDY VGFTLKIFAS
     LLSPVAFGFG CEYFALFEEQ GIGVQWDNLF ESPVEEDGFN LTTSVSMMLF DTFLYGVMTW
     YIEAVFPGQY GIPRPWYFPC TKSYWFGEES DEKSHPGSNQ KRISEICMEE EPTHLKLGVS
     IQNLVKVYRD GMKVAVDGLA LNFYEGQITS FLGHNGAGKT TTMSILTGLF PPTSGTAYIL
     GKDIRSEMST IRQNLGVCPQ HNVLFDMLTV EEHIWFYARL KGLSEKHVKA EMEQMALDVG
     LPSSKLKSKT SQLSGGMQRK LSVALAFVGG SKVVILDEPT AGVDPYSRRG IWELLLKYRQ
     GRTIILSTHH MDEADVLGDR IAIISHGKLC CVGSSLFLKN QLGTGYYLTL VKKDVESSLS
     SCRNSSSTVS YLKKEDSVSQ SSSDAGLGSD HESDTLTIDV SAISNLIRKH VSEARLVEDI
     GHELTYVLPY EAAKEGAFVE LFHEIDDRLS DLGISSYGIS ETTLEEIFLK VAEESGVDAE
     TSDGTLPARR NRRAFGDKQS CLRPFTEDDA ADPNDSDIDP ESRETDLLSG MDGKGSYQVK
     GWKLTQQQFV ALLWKRLLIA RRSRKGFFAQ IVLPAVFVCI ALVFSLIVPP FGKYPSLELQ
     PWMYNEQYTF VSNDAPEDTG TLELLNALTK DPGFGTRCME GNPIPDTPCQ AGEEEWTTAP
     VPQTIMDLFQ NGNWTMQNPS PACQCSSDKI KKMLPVCPPG AGGLPPPQRK QNTADILQDL
     TGRNISDYLV KTYVQIIAKS LKNKIWVNEF RYGGFSLGVS NTQALPPSQE VNDAIKQMKK
     HLKLAKDSSA DRFLNSLGRF MTGLDTKNNV KVWFNNKGWH AISSFLNVIN NAILRANLQK
     GENPSHYGIT AFNHPLNLTK QQLSEVALMT TSVDVLVSIC VIFAMSFVPA SFVVFLIQER
     VSKAKHLQFI SGVKPVIYWL SNFVWDMCNY VVPATLVIII FICFQQKSYV SSTNLPVLAL
     LLLLYGWSIT PLMYPASFVF KIPSTAYVVL TSVNLFIGIN GSVATFVLEL FTDNKLNNIN
     DILKSVFLIF PHFCLGRGLI DMVKNQAMAD ALERFGENRF VSPLSWDLVG RNLFAMAVEG
     VVFFLITVLI QYRFFIRPRP VNAKLSPLND EDEDVRRERQ RILDGGGQND ILEIKELTKI
     YRRKRKPAVD RICVGIPPGE CFGLLGVNGA GKSSTFKMLT GDTTVTRGDA FLNKNSILSN
     IHEVHQNMGY CPQFDAITEL LTGREHVEFF ALLRGVPEKE VGKVGEWAIR KLGLVKYGEK
     YAGNYSGGNK RKLSTAMALI GGPPVVFLDE PTTGMDPKAR RFLWNCALSV VKEGRSVVLT
     SHSMEECEAL CTRMAIMVNG RFRCLGSVQH LKNRFGDGYT IVVRIAGSNP DLKPVQDFFG
     LAFPGSVLKE KHRNMLQYQL PSSLSSLARI FSILSQSKKR LHIEDYSVSQ TTLDQVFVNF
     AKDQSDDDHL KDLSLHKNQT VVDVAVLTSF LQDEKVKESY V
//
